Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection

Journal of Virological Methods

Volumn 188, Issue 1-2, 2013, Pages 153-160

  Chang, Lei ^a   Song, Linan ^a   Fournier, David R ^a   Kan, Cheuk W ^a   Patel, Purvish P ^a   Ferrell, Evan P ^a   Pink, Brian A ^a   Minnehan, Kaitlin A ^a   Hanlon, David W ^a   Duffy, David C ^a   Wilson, David H ^a  

^a QUANTERIX CORPORATION   (United States)

Author keywords

Digital ELISA; HIV; Immunoassay; P24; Single molecule array

Indexed keywords

GAG PROTEIN;

ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL IMMUNOASSAY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS CULTURE;

CLINICAL LABORATORY TECHNIQUES; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 84873320416     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.08.017     Document Type: Article

References (49)

1. Assal A., Barlet V., Deschaseaux M., Dupont I., Gallian P., Guitton C., Morel P., David B., De Micco P. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion 2009, 49:289-300.
2. AVERT. AIDS and HIV Information from AVERT. AVERT, Horsham, United Kingdom. (accessed November 2011). http://www.avert.org/safricastats.htm.
3. Brenner B.G., Roger M., Routy J.P., Moisi D., Ntemgwa M., Matte C., Baril J.G., Thomas R., Rouleau D., Bruneau J., Leblanc R., Legault M., Tremblay C., Charest H., Wainberg M.A. High rates of forward transmission events after acute/early HIV-1 infection. The Journal of Infectious Diseases 2007, 195:951-959.
4. Briggs J.A., Simon M.N., Gross I., Kräusslich H.G., Fuller S.D., Vogt V.M., Johnson M.C. The stoichiometry of Gag protein in HIV-1. Nature Structural & Molecular Biology 2004, 11:672-675.
5. Busch M.P., Kleinman S.H., Jackson B., Stramer S.L., Hewlett I., Preston S. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000, 40:143-159.
6. Busch M.P. Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years. Advances in Transfusion Safety - vol. IV, Developments in Biologicals (Basel) 2007, vol. 127:87-112. S. Karger Publishers, Inc., Farmington, CT.
7. Busch M.P., Glynn S.A., Stramer S.L., Strong D.M., Caglioti S., Wright D.J., Pappalardo B., Kleinman S.H. A new safety strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005, 45:254-264.
8. Chang L., Rissin D.M., Fournier D.R., Piech T., Patel P.P., Wilson D.H., Duffy D.C. Single molecule enzyme-linked immunosorbent assays: theoretical considerations. Journal of Immunological Methods 2012, 378:102-115.
9. Constantine N.T., van der Groen G., Belsey E.M., Tamashiro H. Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS 1994, 8:1715-1720.
10. Custer B., Busch M.P., Marfin A., Petersen L. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Annals of Internal Medicine 2005, 143:486-492.
11. Editorial Improving blood safety worldwide. Lancet 2007, 370:1879-1974.
12. Ekiaby M.E., Lelie N., Allain J.P. Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals 2010, 38:59-64.
13. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., Heldebrant C., Smith R., Conrad A., Kleinman S.H., Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
14. Global blood safety and availability facts and figures from the 2007 blood safety survey. WHO Fact Sheet #279, November 2009.
15. Gous N., Scott L., Perovic O., Venter F., Stevens W. Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples?. Journal of Clinical Microbiology 2010, 48:3407-3409.
16. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., Quinn T.C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
17. Hecht F.M., Busch M.P., Rawal B., Webb M., Rosenberg E., Swanson M., Chesney M., Anderson J., Levy J., Kahn J.O. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002, 16:1119-1129.
18. Hutchinson A.B., Patel P., Sansom S.L., Farnham P.G., Sullivan T.J., Bennett B., Kerndt P.R., Bolan R.K., Heffelfinger J.D., Prabhu V.S., Branson B.M. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Medicine 2010, 7:e1000342.
19. Jackson B.R., Busch M.P., Stramer S.L., AuBuchon J.P. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003, 43:721-729.
20. Kan C.W., Rivnak A.J., Campbell T.G., Piech T., Rissin D.M., Mösl M., Peterça A., Niederberger H-P., Minnehan K.A., Purvish P.P., Ferrell E.P., Meyer R.E., Chang L., Wilson D.H., Fournier D.R., Duffy D.C. Isolation and detection of single molecules on paramagnetic beads using sequential fluid flows in micro fabricated polymer array assemblies. Lab on a Chip 2011, 12:977-985.
21. Karim S.S., Mlisana K., Kharsany A.B., Williamson C., Baxter C., Karim Q.A. Utilizing nucleic acid amplification to identify acute HIV infection. AIDS 2007, 21:653-655.
22. Karris M.Y., Anderson C.M., Morris S.R., Smith D.M., Little S.J. Cost savings associated with testing of antibodies, antigens, and nucleic acids fordiagnosis of acute HIV infection. Journal of Clinical Microbiology 2012, 50:1874-1878.
23. Kontio S. Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants. Journal of Immunological Methods 1991, 139:257-263.
24. Laperche S. Editorial. Blood safety and nucleic acid testing in Europe. Euro Surveillance 2005, 10(2).
25. Marcel M., Grèzeb M., Bailly A., Izopet J. Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. Journal of Clinical Virology 2011, 50:57-60.
26. Marks G., Crepaz N., Janssen R.S. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006, 20:1447-1450.
27. Marshall D.A., Kleinman S.H., Wong J.B., AuBuchon J.P., Grima D.T., Kulin N.A., Weinstein M.C. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sanguinis 2004, 86:28-40.
28. Mullis K.B., Faloona F.A., Scharf S., Saiki R.K., Horn G., Erlich H.A. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symposia on Quantitative Biology 1986, 51:263-273.
29. National Institute of Allergies and Infectious Disease. Structure of HIV. (accessed November 2011). http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Biology/pages/structure.aspx.
30. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., Candal D., Kuehl D., Kennedy M.S., Rudolph D., Luo W., Delatorre N., Masciotra S., Kalish M.L., Cowart F., Barnett T., Lal R., McDougal J.S. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. Journal of Clinical Microbiology 2008, 46:1588-1595.
31. Pao D., Fisher M., Hué S., Dean G., Murphy G., Cane P.A., Sabin C.A., Pillay D. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005, 19:85-90.
32. Piatak M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
33. Procleix ULTRIO Assay Product Insert. 501807-REG Rev. 3. (accessed November 2011). http://www.fda.gov/downloads/biologicsbloodvaccines/bloodbloodproducts/approvedproducts/licensedproductsblas/blooddonorscreening/infectiousdisease/ucm092120.pdf.
34. Rissin D.M., Kan C.W., Campbell T.G., Howes S.C., Fournier D.R., Song L., Piech T., Patel P.P., Chang L., Rivnak A.J., Ferrell E.P., Randall J.D., Provuncher G.K., Walt D.R., Duffy D.C. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nature Biotechnology 2010, 28:595-599.
35. Rissin D.M., Fournier D.R., Piech T., Kan C.W., Campbell T.G., Song L., Chang L., Rivnak A.J., Patel P.P., Provuncher G.K., Ferrell E.P., Howes S., Pink B.A., Minnehan K.A., Wilson D.H., Duffy D.C. Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range. Analytical Chemistry 2011, 83:2279-2285.
36. Rissin D., Walt D. Digital concentration readout of single enzyme molecules using femtoliter arrays and Poisson statistics. Nano Letters 2006, 6:520-523.
37. Rollins G. What's the best testing strategy for HIV infection?. Clinical Laboratory News 2010, 36:1-11.
38. Sanchez-Pescador R., Power M.D., Barr P.J., Steimer K.S., Stempien M.M., Brown-Shimer S.L., Gee W.W., Renard A., Randolph A., Levy J.A. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 1985, 227:484-492.
39. Steimer K.S., Puma J.P., Power M.D., Powers M.A., George-Nascimento C., Stephans J.C., Levy J.A., Sanchez-Pescador R., Luciw P.A., Barr P.J. Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 1986, 150:283-290.
40. Stekler J.D., Swenson P.D., Coombs R.W., Dragavon J., Thomas K.K., Brennan C.A., Devare S.G., Wood R.W., Golden M.R. HIV testing in a high-incidence population: is antibody testing alone good enough?. Clinical Infectious Diseases 2009, 49:444-453.
41. Stevens W., Akkers E., Myers M., Motloung T., Pilcher C., Venter F. High prevalence of undetected, acute HIV infection in a South African primary health care clinic. IAS Conf. HIV Pathol. Treatmt. 2005, (Abstr. MoOa0108).
42. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., Dodd R.Y., Busch M.P. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. The New England Journal of Medicine 2004, 351:760-768.
43. Summers M.F., Henderson L.E., Chance M.R., Bess J.W., South T.L., Blake P.R., Sagi I., Perez-Alvarado G., Sowder R.C., Hare D.R. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Science 1992, 1:563-574.
44. Ukkonen P., Korpela J., Suni J., Hedman K. Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays. European Journal of Clinical Microbiology & Infectious Diseases 1988, 4:518-523.
45. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., Kiwanuka N., Kigozi G., Kiddugavu M., Lutalo T., Nalugoda F., Wabwire-Mangen F., Meehan M.P., Quinn T.C. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. The Journal of Infectious Diseases 2005, 191:1403-1409.
46. Weber B., Fall E.H., Berger A., Doerr H.W. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. Journal of Clinical Microbiology 1998, 36:2235-2239.
47. Westreich D.J., Hudgens M.G., Fiscus S.A., Pilcher C.D. Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. Journal of Clinical Microbiology 2008, 46:1785-1792.
48. Wilson D.H., Hanlon D.W., Provuncher G.K., Chang L., Song L., Patel P.P., Ferrell E.P., Lepor H., Partin A.W., Chan D.W., Sokoll L.J., Cheli C.D., Thiel R.P., Fournier D.R., Duffy D.C. Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology. Clinical Chemistry 2011, 57:1712-1721.
49. Zetterberg H., Mörtberg E., Song L., Chang L., Provuncher G.K., Patel P.P., Ferrell E., Fournier D.R., Kan C.W., Campbell T.G., Meyer R., Rivnak A.J., Pink B.A., Minnehan K.A., Piech T., Rissin D.M., Duffy D.C., Rubertsson S., Wilson D.H., Blennow K. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans. PLoS ONE 2011, 6:e28263.